Reference
Schiro G, et al. Tocilizumab treatment of MOGAD encephalitis nonresponder to Anti CD-20 therapy: efficacy and safety during SARS-COV-2 infection. Multiple Sclerosis Journal 28 (Suppl.): 150, No. 3, Oct 2022. Available from: URL: http://doi.org/10.1177/13524585221123687 [abstract]
Rights and permissions
About this article
Cite this article
Anti-cd20-antibody/tozinameran. Reactions Weekly 1936, 36 (2022). https://doi.org/10.1007/s40278-022-29233-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-29233-1